Patents Assigned to Zalicus Inc.
  • Compositions and methods for treatment of filovirus-mediated diseases
    Patent number: 8475804
    Abstract: The invention features compositions, methods, and kits useful for the treatment of filovirus-mediated diseases, e.g., hemorrhagic fever caused by Ebola virus, in an animal.
    Type: Grant
    Filed: February 22, 2010
    Date of Patent: July 2, 2013
    Assignees: U.S. Army Medical Research and Material Command, Zalicus, Inc.
    Inventors: Lisa M. Johansen, Joseph Lehár, Benjamin G. Hoffstrom, Gene G. Olinger, Andrea R. Stossel
  • METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF OPHTHALMIC DISORDERS
    Publication number: 20120322746
    Abstract: The invention features methods, kits, and compositions for the treatment of ophthalmic disorders. The compositions include a corticosteroid in combination with a non-steroidal immunophilin-dependent immunosuppressant.
    Type: Application
    Filed: August 29, 2012
    Publication date: December 20, 2012
    Applicant: Zalicus, Inc.
    Inventors: Todd W. Chappell, M. James Nichols, Daniel S. Grau
  • Methods, compositions, and kits for the treatment of ophthalmic disorders
    Patent number: 8258153
    Abstract: The invention features methods, kits, and compositions for the treatment of ophthalmic disorders. The compositions include a corticosteroid in combination with a non-steroidal immunophilin-dependent immunosuppressant.
    Type: Grant
    Filed: November 28, 2011
    Date of Patent: September 4, 2012
    Assignee: Zalicus, Inc.
    Inventors: Todd W. Chappell, M. James Nichols, Daniel S. Grau
  • METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF OPHTHALMIC DISORDERS
    Publication number: 20120077756
    Abstract: The invention features methods, kits, and compositions for the treatment of ophthalmic disorders. The compositions include a corticosteroid in combination with a non-steroidal immunophilin-dependent immunosuppressant.
    Type: Application
    Filed: November 28, 2011
    Publication date: March 29, 2012
    Applicant: Zalicus Inc.
    Inventors: Todd W. Chappell, M. James Nichols, Daniel S. Grau
  • METHODS AND REAGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS
    Publication number: 20120058979
    Abstract: The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering to the patient a tetra-substituted pyrimidopyrimidine, either alone or in combination with one or more additional agents. The invention also features a composition containing a tetra-substituted pyrimidopyrimidine in combination with one or more additional agents.
    Type: Application
    Filed: November 9, 2011
    Publication date: March 8, 2012
    Applicant: Zalicus Inc.
    Inventors: Curtis Keith, Alexis Borisy, Grant R. Zimmermann, Edward Roydon Jost-Price, Palaniyandi Manivasakam, Nicole Hurst, Michael A. Foley, Michael S. Slavonic, Brendan Smith, Benjamin A. Auspitz
  • Methods and reagents for the treatment of immunoinflammatory disorders
    Patent number: 8080553
    Abstract: The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering to the patient a tetra-substituted pyrimidopyrimidine, either alone or in combination with one or more additional agents. The invention also features a composition containing a tetra-substituted pyrimidopyrimidine in combination with one or more additional agents.
    Type: Grant
    Filed: September 7, 2006
    Date of Patent: December 20, 2011
    Assignee: Zalicus Inc.
    Inventors: Curtis Keith, Alexis Borisy, Grant R. Zimmermann, Edward Roydon Jost-Price, Palaniyandi Manivasakam, Nicole Hurst, Michael A. Foley, Michael S. Slavonic, Brendan Smith, Benjamin A. Auspitz
  • Methods, compositions, and kits for the treatment of ophthalmic disorders
    Patent number: 8067433
    Abstract: The invention features methods, kits, and compositions for the treatment of ophthalmic disorders. The compositions include a corticosteroid in combination with a non-steroidal immunophilin-dependent immunosuppressant.
    Type: Grant
    Filed: November 8, 2006
    Date of Patent: November 29, 2011
    Assignee: Zalicus Inc.
    Inventors: Todd W. Chappell, M. James Nichols, Daniel S. Grau
  • Combinations for the treatment of immunoinflammatory disorders
    Patent number: 7915265
    Abstract: The invention features pharmaceutical compositions that include dipyridamole and a corticosteroid.
    Type: Grant
    Filed: February 15, 2006
    Date of Patent: March 29, 2011
    Assignee: Zalicus Inc.
    Inventors: Curtis Keith, Alexis Borisy, Grant Zimmermann, Edward Roydon Jost-Price, Palaniyandi Manivasakam, Nicole W. Hurst, Michael A. Foley